#news #biotech New CRISPR-Cas9 variants can respond to viral proteases

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New CRISPR-Cas9 variants can respond to viral proteases .Using a technique called circular permutation, researchers at the University of California Berkeley have created a new suite of Cas9 variants called Cas9-CPs, which will simplify design of Cas9-fusion proteins for diverse applications beyond simple DNA cutting, such as base editing and epigenetic modifications. The work appears January 10 in the journal Cell.

from Biotechnology News – Biology News http://bit.ly/2D1s293